Global Coil Coatings Market Will Reach USD 8.53 Billion by 2024: Zion Market Research
/
Date20 Jul 2018
New York, NY, July 20, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Coil Coatings Market by Types (Silicone-Modified Polyester,... Read More →
SmartCard Marketing Systems Inc (OTC:SMKG) Releases Granularchain.com White Paper, Sandbox with API’s for its Blockchain Accelerating Adoption by FI’s, ICO’s & MSB’s
/
Date20 Jul 2018
New York, July 20, 2018 (GLOBE NEWSWIRE) — “Tech Trends 2018” included a section titled “Blockchain to blockchains: Broad adoption and integration enter the realm... Read More →
Mullen Group Ltd. Announces Declaration of Monthly Dividend
/
Date20 Jul 2018
OKOTOKS, Alberta, July 20, 2018 (GLOBE NEWSWIRE) — (TSX:MTL) The Board of Directors of Mullen Group Ltd. (“Mullen Group” and/or the “Corporation“) announced today that... Read More →
Bank of the James Announces Second Quarter, First Half 2018 Financial Results and Declaration of Dividend
/
Date20 Jul 2018
LYNCHBURG, Va., July 20, 2018 (GLOBE NEWSWIRE) — Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the... Read More →
SJW Group and Connecticut Water File New Application with Connecticut Public Utilities Regulatory Authority for Approval of Merger of Equals
/
Date20 Jul 2018
San Jose, Calif. and Clinton, Conn., July 20, 2018 (GLOBE NEWSWIRE) — Companies Moving Forward to Secure Required Approvals for Planned Close During Fourth Quarter... Read More →
Rosetta Stone to Report Second Quarter 2018 Results on August 2
/
Date20 Jul 2018
Arlington, July 19, 2018 (GLOBE NEWSWIRE) — Rosetta Stone to Report Second Quarter 2018 Results on August 2 ARLINGTON, July 19, 2018 – Rosetta Stone... Read More →
Ubiquitech Reports 2018 Second Quarter Revenues of $948,584 and Earnings of $151,870
/
Date20 Jul 2018
Denver, CO., July 17, 2018 (GLOBE NEWSWIRE) — Ubiquitech Software Corp. (OTC: UBQU), through its operating subsidiary HempLifeToday.com, today announced its second quarter 2018 financial... Read More →
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
/
Date20 Jul 2018
TIBSOVO 250 mg bottle TIBSOVO 250 mg bottle Agios Pharmaceuticals, Inc. TIBSOVO TIBSOVO Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass., July 20, 2018 (GLOBE NEWSWIRE) — –... Read More →
Replimune Announces Pricing of Initial Public Offering
/
Date20 Jul 2018
WOBURN, Mass., July 19, 2018 (GLOBE NEWSWIRE) — Replimune Group, Inc., a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced the... Read More →